tradingkey.logo
tradingkey.logo
Search

Cardinal Health Inc

CAH
Add to Watchlist
225.750USD
+0.370+0.16%
Close 09-21 16:00ET
52.59BMarket Cap
34.37P/E TTM
After-hours 19:00 (ET)225.750USD+0.090+0.04%

Cardinal Health Inc (CAH) Stock Price Target & Forecast

Analyst Rating

Based on 19 analysts giving stock ratings to Cardinal Health Inc in the past month.

Buy
7 Strong Buy
10 Buy
2 Hold
0 Sell
0 Strong Sell
Target Price
272.044USD+20.70%

CAH Analyst Recommendation Trends

In the current month, CAH has received 10 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. CAH average Analyst price target in the last month is 272.044.

2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
Strong Buy
7
7
7
6
6
6
5
5
Buy
10
10
10
10
10
10
10
9
Hold
2
2
2
2
2
2
3
3
Strong Sell
0
0
0
0
0
0
0
0
Sell
0
0
0
0
0
0
0
0
Total
19
19
19
18
18
18
18
17

CAH Analyst Rating for Peer Comparison

Updated: Sep 21, 2026
Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Ratings
Analysts
Biogen Inc
BIIB
7
17
12
1
0
37
Amgen Inc
AMGN
4
12
18
2
1
37
Eli Lilly and Co
LLY
10
17
6
1
0
34
AbbVie Inc
ABBV
8
19
6
0
0
33
Merck & Co Inc
MRK
8
14
10
0
0
32
Pfizer Inc
PFE
5
6
19
1
1
32
Regeneron Pharmaceuticals Inc
REGN
6
15
11
0
0
32
Gilead Sciences Inc
GILD
7
18
6
0
0
31
Vertex Pharmaceuticals Inc
VRTX
9
16
5
0
1
31
Alnylam Pharmaceuticals Inc
ALNY
5
18
7
0
0
30

Financial Forecasting

Based on analysts' estimates, CAH EPS is projected to reach 2.934 in FY2027Q1, following reported EPS of 1.708 in FY2026Q4. Track earnings expectations against reported figures to see how profitability is evolving.

EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2026Q2
FY2026Q3
FY2026Q4
FY2027Q1
FY2027Q2
Forecast
2.38
2.79
2.42
2.93
3.11
Actual
1.98
1.70
1.71
--
--
Surprise
-16.85%
-39.10%
-29.42%
--
--

FAQs

What is Cardinal Health Inc's expected revenue for the next quarter?

Cardinal Health Inc's expected revenue is 66.71B.

What is Cardinal Health Inc's price target?

Analysts forecast that Cardinal Health Inc's price target is USD 272.04, with the highest forecast at USD 292.00 and the lowest forecast at USD 239.70.

How have Cardinal Health IncCAH's recent earnings per share performed?

The market expectation was USD 1.71, while Cardinal Health IncCAH's earnings per share (EPS) for the previous quarter was USD 1.70. EPS for the next quarter is expected at USD 2.93.

What is the analyst rating for Cardinal Health Inc?

Based on the ratings of Cardinal Health Inc's stock from 19 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.